Sihuan Pharmaceutical Holdings expects net profit for the six months ended June 30, 2026 to be no less than RMB 210 million, up at least 217.2% from a year earlier, according to Ming Pao.
The company also said revenue is expected to be at least RMB 1.14 billion, broadly unchanged from the same period last year.
STOCKS | Sino Biopharmaceutical Unit Sees H1 Net Profit Rise At Least 217.2%
2026-07-27 04:58:27
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
